Studies elucidating the role of immune evasion by tumor cells have led to several revelations, including the generation of combined positive score (CPS) based on PD‐L1 expression in tumor cells for the assessment of treatment response in HNSCC. The gene discussed is CD274; the disease is neoplasm.